These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30244475)

  • 1. Design, graph theoretical analysis, density functionality theories, Insilico modeling, synthesis, characterization and biological activities of novel thiazole fused quinazolinone derivatives.
    Saravanan G; Panneerselvam T; Alagarsamy V; Kunjiappan S; Parasuraman P; Murugan I; Dinesh Kumar P
    Drug Dev Res; 2018 Sep; 79(6):260-274. PubMed ID: 30244475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2-(methyl/phenyl)-3-(4-(5-substituted-1,3,4-oxadiazol-2-yl) phenyl) quinazolin-4(3H)-ones as NMDA receptor inhibitor.
    Saravanan G; Panneerselvam T; Kunjiappan S; Parasuraman P; Alagarsamy V; Udayakumar P; Soundararajan M; Joshi SD; Ramalingam S; Ammunje DN
    Drug Dev Res; 2019 May; 80(3):368-385. PubMed ID: 30609096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity.
    Jain N; Jaiswal J; Pathak A; Singour PK
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):63-73. PubMed ID: 28056730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.
    Ugale VG; Bari SB
    Arch Pharm (Weinheim); 2016 Nov; 349(11):864-880. PubMed ID: 27680868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
    Jatav V; Mishra P; Kashaw S; Stables JP
    Eur J Med Chem; 2008 Sep; 43(9):1945-54. PubMed ID: 18222569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents.
    Amir M; Ali I; Hassan MZ
    Arch Pharm Res; 2013 Jan; 36(1):61-8. PubMed ID: 23325491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and anticonvulsant activities of novel 1-(substituted/unsubstituted benzylidene)-4-(4-(6,8-dibromo-2-(methyl/phenyl)-4-oxoquinazolin-3(4H)-yl)phenyl) semicarbazide derivatives.
    Saravanan G; Alagarsamy V; Prakash CR
    Bioorg Med Chem Lett; 2012 May; 22(9):3072-8. PubMed ID: 22487180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea.
    Kashaw SK; Kashaw V; Mishra P; Jain NK; Stables JP
    Eur J Med Chem; 2009 Nov; 44(11):4335-43. PubMed ID: 19674817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor.
    Zayed MF; Ihmaid SK; Ahmed HE; El-Adl K; Asiri AM; Omar AM
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28125041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Anticonvulsant Activity, and SAR Study of Novel 4-Quinazolinone Derivatives.
    Noureldin NA; Kothayer H; Lashine EM; Baraka MM; El-Eraky W; Awdan SA
    Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28177550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Biological Evaluation of 6-(2-Amino-substituted phenyl)-4-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Anticonvulsant Agents.
    Khan AA; Siddiqui N; Akhtar MJ; Ali Z; Yar MS
    Arch Pharm (Weinheim); 2016 Apr; 349(4):277-92. PubMed ID: 26996080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Synthesis of 5-Substituted Benzo[d][1,3]dioxole Derivatives as Potent Anticonvulsant Agents.
    Dong S; Wang T; Hu C; Chen X; Jin Y; Wang Z
    Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28092111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of some new 1-phenyl-3/4-[4-(aryl/heteroaryl/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents.
    Mishra CB; Kumari S; Tiwari M
    Arch Pharm Res; 2016 May; 39(5):603-17. PubMed ID: 26891908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vivo and in silico evaluation of novel 2,3-dihydroquinazolin-4(1H)-one derivatives as potential anticonvulsant agents.
    Kothayer H; Ibrahim SM; Soltan MK; Rezq S; Mahmoud SS
    Drug Dev Res; 2019 May; 80(3):343-352. PubMed ID: 30565722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations.
    Shafie A; Mohammadi-Khanaposhtani M; Asadi M; Rahimi N; Ranjbar PR; Ghasemi JB; Larijani B; Mahdavi M; Shafaroodi H; Dehpour AR
    Mol Divers; 2020 Feb; 24(1):179-189. PubMed ID: 30895449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
    Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
    Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular modeling studies, and anticonvulsant evaluation of novel 1-((2-hydroxyethyl)(aryl)amino)-N-substituted cycloalkanecarboxamides and their acetate esters.
    Aboul-Enein MN; El-Azzouny AA; Amin KM; Aboutabl ME; Abo-Elmagd MI
    Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800269. PubMed ID: 30461033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, anticonvulsant evaluation and docking study of 2-[(6-substituted benzo[d]thiazol-2-ylcarbamoyl)methyl]-1-(4-substituted phenyl)isothioureas.
    Siddiqui N; Alam MS; Sahu M; Naim MJ; Yar MS; Alam O
    Bioorg Chem; 2017 Apr; 71():230-243. PubMed ID: 28238402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant and Neurotoxicity of Some Novel 1-([1,3,4]thiadiazino[6,5- b]indol-3-yl Semicarbazides.
    Deshmukh R; Thakur AS; Jha AK; Kumar SP
    Cent Nerv Syst Agents Med Chem; 2015; 16(1):29-36. PubMed ID: 26100150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Docking Study of Pyrimidine-Triazine Hybrids for GABA Estimation in Animal Epilepsy Models.
    Sahu M; Siddiqui N; Naim MJ; Alam O; Yar MS; Sharma V; Wakode S
    Arch Pharm (Weinheim); 2017 Sep; 350(9):. PubMed ID: 28758238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.